| 货号 | 10005823-100mg |
| 描述 | The endocannabinoids present a rich system of central cannabinoid (CB1), peripheral cannabinoid (CB2), and non-CB receptor-mediated pharmacology that has stimulated research in many fields including memory, weight loss and appetite, neurodegeneration, tumor surveillance, analgesia, and inflammation.1,2 Docosanoyl ethanolamide is a saturated N-acylethanolamide. Non-cannabinoid receptor-mediated pharmacology of the saturated ethanolamides is still being elucidated.3 Other studies indicate they may have a role in the functioning of ion channels.4 |
| 供应商 | Cayman |
| 应用文献 | |
| 1.Pertwee, R.G. Pharmacology of cannabinoid receptor ligands. Current Medicinal Chemistry 6, 635-664 (1999). 2.Martin, B.R.,Mechoulam, R., and Razdan, R.K. Discovery and characterization of endogenous cannabinoids. Life Sciences 65, 573-595 (1999). 3.Smart, D.,Jonsson, K.O.,Vandevoorde, S., et al. “Entourage” effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. British Journal of Pharmacology 136, 452-458 (2002). 4.Oz, M.,Alptekin, A.,Tchugunova, Y., et al. Effects of saturated long-chain N-acylethanolamines on voltage-dependent Ca2+ fluxes in rabbit T-tubule membranes. Archives of Biochemistry and Biophysics 434, 344-351 (2005). | |
| 运输条件 | Wet ice in continental US; may vary elsewhere |
| 存放说明 | -20 |
| 纯度 | ≥98% |
| 计算分子量 | 383.7 |
| 分子式 | C24H49NO2 |
| CAS号 | 94109-05-4 |
| 稳定性 | ≥ 2 years |
| 本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。 |